X-linked fetal akinesia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:995
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked fetal akinesia syndrome, also known as X-linked lethal arthrogryposis with intrauterine growth retardation (IUGR), is an extremely rare and severe genetic disorder characterized by markedly reduced or absent fetal movement during pregnancy. This condition predominantly affects males and is caused by mutations in genes on the X chromosome. The syndrome falls within the broader spectrum of fetal akinesia deformation sequence (FADS), in which lack of fetal movement leads to a cascade of secondary developmental abnormalities. The hallmark features include severe arthrogryposis multiplex congenita (multiple joint contractures), intrauterine growth restriction, fetal hydrops (abnormal fluid accumulation), pulmonary hypoplasia (underdeveloped lungs), and characteristic facial anomalies such as a small jaw (micrognathia) and low-set ears. Polyhydramnios (excess amniotic fluid) is frequently observed during pregnancy due to impaired fetal swallowing. The musculoskeletal, respiratory, and central nervous systems are primarily affected. Thin, gracile bones and decreased muscle mass are commonly noted. Pterygia (skin webbing across joints) and cystic hygroma may also be present. The prognosis is extremely poor, with most affected males dying in utero or shortly after birth, primarily due to respiratory failure from pulmonary hypoplasia. Female carriers are typically unaffected or may show very mild features. There is currently no curative treatment available. Management is supportive and palliative. Genetic counseling is essential for affected families, and prenatal diagnosis may be possible through ultrasound detection of reduced fetal movements and molecular genetic testing when the causative mutation has been identified in the family.

Also known as:

Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked fetal akinesia syndrome.

View clinical trials →

No actively recruiting trials found for X-linked fetal akinesia syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked fetal akinesia syndrome community →

No specialists are currently listed for X-linked fetal akinesia syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked fetal akinesia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked fetal akinesia syndromeForum →

No community posts yet. Be the first to share your experience with X-linked fetal akinesia syndrome.

Start the conversation →

Latest news about X-linked fetal akinesia syndrome

No recent news articles for X-linked fetal akinesia syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about X-linked fetal akinesia syndrome

What is X-linked fetal akinesia syndrome?

X-linked fetal akinesia syndrome, also known as X-linked lethal arthrogryposis with intrauterine growth retardation (IUGR), is an extremely rare and severe genetic disorder characterized by markedly reduced or absent fetal movement during pregnancy. This condition predominantly affects males and is caused by mutations in genes on the X chromosome. The syndrome falls within the broader spectrum of fetal akinesia deformation sequence (FADS), in which lack of fetal movement leads to a cascade of secondary developmental abnormalities. The hallmark features include severe arthrogryposis multiplex

How is X-linked fetal akinesia syndrome inherited?

X-linked fetal akinesia syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked fetal akinesia syndrome typically begin?

Typical onset of X-linked fetal akinesia syndrome is neonatal. Age of onset can vary across affected individuals.